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Incidence rates and hazard ratios of nephrolithiasis and cases of renal failure in patients on atazanavir, other PIs and PI-free regimens

  Cohort       Nephrolithiasis cases/person-years (py)   Nephrolithiasis incidence rate per 1,000 py (95% CI)   ATV vs other PIs adjusted HR (95% CI)   ATV vs PI-free adjusted HR (95% CI)   Acute renal failure cases   Chronic renal failure cases
  ------------ ----------------------------------------- ------------------------------------------------------ --------------------------------------- ------------------------------------- --------------------------- -----------------------------
  Commercial                                                                                                                                                                                                              
   ATV         61/4,865                                  12.5 (9.4, 15.7)                                       1.26 (0.85, 1.87)                       1.65 (1.15, 2.37)                     1                           3
   Other PIs   44/4,315                                  10.2 (7.2, 13.2)                                       Reference                                                                     3                           0
   PI-free     67/8,662                                  7.7 (5.9, 9.6)                                                                                 Reference                             2                           1
  Medicaid                                                                                                                                                                                                                
   ATV         37/3,460                                  17.4 (12.2, 23.9)                                      0.93 (0.58, 1.50)                       1.31 (0.74, 2.39)                     5                           3
   Other PIs   34/3,117                                  20.4 (14.1, 28.5)                                      Reference                                                                     3                           0
   PI-free     27/2,527                                  15.1 (10.0, 22.0)                                                                              Reference                             2                           1

Abbreviations: ATV, atazanavir, CI, confidence interval, HR, hazard ratio, PI, protease inhibitor, py, person-years.

All comparative analyses were conducted using propensity score stratification adjustment for baseline patient characteristics.
